Issue 9/2006
Content (10 Articles)
Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework
Emma McIntosh
Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003
Yue-Chune Lee, Ming-Chin Yang, Yu-Tung Huang, Chien-Hsiang Liu, Sun-Bing Chen
Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia
John H. Wlodarczyk, Leslie G. Cleland, Anne M. Keogh, Keith D. McNeil, Kate Perl, Robert G. Weintraub, Trevor J. Williams
Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes
Andrew J. Palmer, Craig J. Currie
The Authors’ Reply
Adrian A. Bagust, Marc Evans, Sophie Beale, Philip Home, Andrew Perry, Murray Stewart, Arran Shearer, Alan Martin, Lisa Hulme, Andreas Liebl, Oliver Schoeffski, Anita Goertz, Javier Ampudia-Blasco, Belen Martinez-Lage, Isabel Perez Escolano, Gonzalo Paris